Nifty
:
24834.85
Sensex
:
81332.72
428.75 (1.76%)
1292.92 (1.62%)
Nifty
Sensex
:
:
24834.85
81332.72
428.75 (1.76%)
1292.92 (1.62%)

Shilpa Medicare Ltd.

Pharmaceuticals & Drugs - Global

Rating :
45/99

BSE: 530549 | NSE: SHILPAMED

NSE BSE
660.20
05-Jul-2024
  • Open
  • High
  • Low
  • Previous Close
  •  601.00
  •  677.00
  •  601.00
  •  579.65
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  4067699
  •  26592.90
  •  685.00
  •  296.80

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 6,512.39
  • 204.32
  • 1
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 7,417.54
  • N/A
  • 2.82

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 44.39%
  • 12.26%
  • 24.68%
  • FII
  • DII
  • Others
  • 9.08%
  • 6.28%
  • 3.31%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 6.27
  • 7.44
  • 5.23

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -2.69
  • -10.53
  • -12.46

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 30.99
  • 24.84
  • 62.27

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 3.02
  • 2.18
  • 1.99

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 22.00
  • 20.94
  • 24.08

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 24
Mar 23
Var%
Dec 23
Dec 22
Var%
Sep 23
Sep 22
Var%
Jun 23
Jun 22
Var%
Net Sales
291.69
263.56
10.67%
286.48
262.50
9.14%
312.98
262.91
19.04%
260.18
261.16
-0.38%
Expenses
221.63
225.34
-1.65%
220.54
231.21
-4.61%
252.68
250.71
0.79%
212.26
240.59
-11.78%
EBITDA
70.06
38.23
83.26%
65.95
31.29
110.77%
60.30
12.20
394.26%
47.92
20.57
132.96%
EBIDTM
24.02%
14.50%
23.02%
11.92%
19.27%
4.64%
18.42%
7.88%
Other Income
2.49
2.17
14.75%
2.21
2.74
-19.34%
1.81
4.39
-58.77%
1.93
8.10
-76.17%
Interest
24.20
17.74
36.41%
26.22
17.86
46.81%
23.24
13.47
72.53%
18.15
9.59
89.26%
Depreciation
26.63
25.69
3.66%
26.71
24.08
10.92%
27.79
23.31
19.22%
26.75
22.42
19.31%
PBT
27.85
-3.03
-
15.23
-7.91
-
11.08
-20.20
-
4.95
-3.34
-
Tax
3.21
3.82
-15.97%
9.46
-0.96
-
7.60
-3.81
-
2.11
-6.41
-
PAT
24.64
-6.85
-
5.77
-6.95
-
3.48
-16.38
-
2.84
3.08
-7.79%
PATM
8.45%
-2.60%
2.01%
-2.65%
1.11%
-6.23%
1.09%
1.18%
EPS
2.82
-0.93
-
0.53
-0.76
-
0.19
-2.15
-
0.14
0.10
40.00%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Net Sales
1,151.33
1,050.11
1,145.52
901.13
907.91
733.39
788.83
779.16
716.43
613.80
571.38
Net Sales Growth
9.64%
-8.33%
27.12%
-0.75%
23.80%
-7.03%
1.24%
8.76%
16.72%
7.42%
 
Cost Of Goods Sold
407.26
415.92
383.22
270.73
277.73
257.03
355.87
371.81
366.19
323.16
313.26
Gross Profit
744.07
634.19
762.30
630.40
630.18
476.36
432.95
407.36
350.25
290.63
258.12
GP Margin
64.63%
60.39%
66.55%
69.96%
69.41%
64.95%
54.89%
52.28%
48.89%
47.35%
45.17%
Total Expenditure
907.11
961.84
948.32
729.43
693.39
579.39
637.60
617.55
556.44
487.38
455.40
Power & Fuel Cost
-
56.79
52.43
40.25
38.76
33.57
28.86
26.30
21.90
19.29
17.37
% Of Sales
-
5.41%
4.58%
4.47%
4.27%
4.58%
3.66%
3.38%
3.06%
3.14%
3.04%
Employee Cost
-
287.33
264.49
235.31
196.59
176.40
149.35
127.87
90.09
82.30
67.83
% Of Sales
-
27.36%
23.09%
26.11%
21.65%
24.05%
18.93%
16.41%
12.57%
13.41%
11.87%
Manufacturing Exp.
-
110.44
124.11
91.29
79.19
61.23
59.96
52.55
45.35
36.55
27.44
% Of Sales
-
10.52%
10.83%
10.13%
8.72%
8.35%
7.60%
6.74%
6.33%
5.95%
4.80%
General & Admin Exp.
-
46.83
71.58
47.71
70.26
27.20
22.50
16.95
14.11
10.64
9.53
% Of Sales
-
4.46%
6.25%
5.29%
7.74%
3.71%
2.85%
2.18%
1.97%
1.73%
1.67%
Selling & Distn. Exp.
-
18.56
18.02
18.63
10.40
6.72
6.37
4.75
7.27
5.99
7.29
% Of Sales
-
1.77%
1.57%
2.07%
1.15%
0.92%
0.81%
0.61%
1.01%
0.98%
1.28%
Miscellaneous Exp.
-
25.98
34.49
25.51
20.47
17.23
14.68
17.32
11.54
9.45
7.29
% Of Sales
-
2.47%
3.01%
2.83%
2.25%
2.35%
1.86%
2.22%
1.61%
1.54%
2.22%
EBITDA
244.23
88.27
197.20
171.70
214.52
154.00
151.23
161.61
159.99
126.42
115.98
EBITDA Margin
21.21%
8.41%
17.21%
19.05%
23.63%
21.00%
19.17%
20.74%
22.33%
20.60%
20.30%
Other Income
8.44
31.41
20.90
40.09
22.22
15.56
32.62
29.34
11.36
6.93
9.12
Interest
91.81
58.65
41.17
21.87
4.56
3.68
2.66
3.13
3.93
4.05
3.52
Depreciation
107.88
95.50
79.80
53.98
43.78
42.06
37.22
30.64
23.14
21.41
23.22
PBT
59.11
-34.47
97.13
135.95
188.40
123.82
143.96
157.17
144.28
107.89
98.35
Tax
22.38
-7.36
41.68
48.85
33.49
26.18
33.91
42.04
35.62
35.22
20.30
Tax Rate
37.86%
21.35%
39.35%
24.82%
17.78%
18.22%
23.56%
27.54%
25.11%
32.66%
21.27%
PAT
36.73
-32.48
60.66
147.78
156.50
120.28
112.43
113.71
109.84
73.69
75.67
PAT before Minority Interest
36.65
-30.92
60.58
146.20
154.91
117.52
110.05
110.59
106.24
72.62
75.15
Minority Interest
-0.08
-1.56
0.08
1.58
1.59
2.76
2.38
3.12
3.60
1.07
0.52
PAT Margin
3.19%
-3.09%
5.30%
16.40%
17.24%
16.40%
14.25%
14.59%
15.33%
12.01%
13.24%
PAT Growth
235.54%
-
-58.95%
-5.57%
30.11%
6.98%
-1.13%
3.52%
49.06%
-2.62%
 
EPS
3.76
-3.32
6.20
15.11
16.00
12.30
11.50
11.63
11.23
7.53
7.74

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Shareholder's Funds
1,783.28
1,822.19
1,478.67
1,329.36
1,197.58
1,085.03
986.90
639.26
546.94
396.45
Share Capital
8.68
8.68
8.15
8.15
8.15
8.15
8.01
7.71
7.71
7.36
Total Reserves
1,774.60
1,813.51
1,470.51
1,321.21
1,189.43
1,076.88
978.88
631.55
539.23
389.09
Non-Current Liabilities
345.11
452.82
561.37
256.94
166.62
153.48
251.26
67.23
154.15
104.53
Secured Loans
242.92
353.49
473.87
164.48
80.39
67.09
141.20
0.03
71.03
37.43
Unsecured Loans
45.90
0.11
0.35
0.53
0.70
1.03
1.30
0.00
31.30
30.05
Long Term Provisions
17.65
19.08
15.48
26.17
21.77
20.32
16.89
13.96
11.75
9.93
Current Liabilities
782.91
611.54
543.29
410.82
253.44
265.84
236.90
222.07
189.06
166.84
Trade Payables
144.41
146.04
67.25
92.55
80.72
103.74
111.86
106.48
75.50
92.98
Other Current Liabilities
273.63
240.13
219.33
142.10
81.62
59.59
28.03
36.49
49.32
38.23
Short Term Borrowings
344.17
202.90
243.40
165.27
86.58
98.12
92.41
74.10
58.47
30.27
Short Term Provisions
20.70
22.46
13.31
10.89
4.52
4.39
4.60
5.00
5.77
5.37
Total Liabilities
2,902.38
2,875.50
2,572.16
1,989.21
1,610.02
1,499.13
1,472.22
930.89
904.54
677.83
Net Block
1,368.33
1,341.84
1,110.53
650.44
558.01
534.20
491.93
393.41
316.06
294.42
Gross Block
1,846.68
1,727.09
1,421.10
986.42
853.16
793.24
704.89
582.20
476.34
448.38
Accumulated Depreciation
478.35
385.25
310.57
335.98
295.15
259.04
212.96
188.79
160.28
153.96
Non Current Assets
2,134.37
1,988.30
1,729.60
1,365.35
1,064.96
827.16
742.33
576.68
576.77
443.89
Capital Work in Progress
655.33
506.18
541.29
666.25
429.12
209.85
140.51
91.90
221.62
111.03
Non Current Investment
42.66
34.23
21.22
10.45
2.25
20.79
27.99
34.15
0.19
0.21
Long Term Loans & Adv.
56.58
93.90
43.10
32.42
48.75
37.47
77.09
51.86
38.74
38.18
Other Non Current Assets
11.47
12.15
13.46
5.78
26.84
24.86
4.80
5.36
0.16
0.06
Current Assets
768.01
887.19
818.99
623.85
545.06
671.97
729.88
354.21
327.61
233.74
Current Investments
0.00
0.00
0.00
0.00
0.00
119.54
224.62
59.63
65.35
10.14
Inventories
319.82
355.24
316.84
226.43
187.67
188.71
190.00
134.23
130.78
123.25
Sundry Debtors
324.35
386.33
217.50
246.79
203.73
220.27
170.93
125.43
81.37
67.96
Cash & Bank
21.56
34.11
123.11
44.56
94.54
73.83
100.39
11.03
18.42
9.19
Other Current Assets
102.28
9.36
98.73
76.81
59.12
69.62
43.95
23.90
31.69
23.20
Short Term Loans & Adv.
87.94
102.16
62.81
29.25
14.08
43.54
21.95
8.90
4.91
3.23
Net Current Assets
-14.90
275.66
275.69
213.04
291.62
406.13
492.98
132.14
138.55
66.90
Total Assets
2,902.38
2,875.49
2,548.59
1,989.20
1,610.02
1,499.13
1,472.21
930.89
904.54
677.83

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Cash From Operating Activity
226.17
105.13
46.93
124.38
146.78
44.92
37.48
128.70
68.81
70.04
PBT
-38.28
102.26
196.79
188.40
143.70
136.77
146.49
140.36
107.84
95.45
Adjustment
148.15
109.34
4.03
41.32
20.44
18.83
17.19
20.61
26.46
19.62
Changes in Working Capital
148.68
-71.99
-106.29
-63.15
18.71
-69.66
-92.61
-2.70
-40.11
-23.44
Cash after chg. in Working capital
258.55
139.62
94.53
166.57
182.85
85.94
71.08
158.27
94.19
91.62
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-32.37
-34.48
-47.60
-42.20
-36.07
-41.02
-33.60
-29.56
-25.38
-21.58
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-278.48
-285.50
-404.28
-289.52
-196.16
-8.76
-262.23
-109.20
-195.18
-48.93
Net Fixed Assets
-22.18
384.16
-272.02
-4.28
-256.96
-136.75
-172.23
-92.14
-78.46
-61.02
Net Investments
-6.42
-18.18
-125.84
-4.44
141.85
95.51
-172.72
-14.09
-64.38
12.08
Others
-249.88
-651.48
-6.42
-280.80
-81.05
32.48
82.72
-2.97
-52.34
0.01
Cash from Financing Activity
45.80
82.86
436.37
175.50
10.06
-60.91
312.70
-19.65
135.05
-28.34
Net Cash Inflow / Outflow
-6.51
-97.51
79.03
10.36
-39.32
-24.75
87.95
-0.15
8.68
-7.23
Opening Cash & Equivalents
25.34
122.85
44.31
34.13
73.83
99.97
7.05
3.61
9.19
16.87
Closing Cash & Equivalent
18.82
25.34
123.34
44.31
34.36
73.83
99.97
6.43
18.42
9.19

Financial Ratios

Consolidated /

Standalone
Description
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Book Value (Rs.)
205.44
209.93
181.37
163.06
146.89
133.09
123.17
82.91
70.92
107.72
ROA
-1.07%
2.20%
6.33%
8.61%
7.56%
7.41%
9.20%
11.58%
9.18%
12.23%
ROE
-1.71%
3.67%
10.41%
12.26%
10.30%
10.62%
13.60%
17.92%
15.40%
20.98%
ROCE
0.80%
5.94%
10.73%
12.41%
11.05%
11.71%
15.91%
19.90%
17.90%
20.48%
Fixed Asset Turnover
0.59
0.73
0.75
0.99
0.89
1.06
1.22
1.36
1.34
1.54
Receivable days
123.51
98.75
94.03
90.56
105.51
90.20
69.00
52.26
43.99
34.62
Inventory Days
117.32
109.68
110.03
83.24
93.66
87.32
75.49
66.97
74.84
62.33
Payable days
127.45
106.00
107.72
47.69
58.00
61.51
60.89
60.10
62.86
57.06
Cash Conversion Cycle
113.38
102.43
96.33
126.11
141.17
116.00
83.61
59.13
55.97
39.90
Total Debt/Equity
0.45
0.37
0.57
0.29
0.16
0.18
0.24
0.14
0.34
0.30
Interest Cover
0.35
3.48
9.92
42.34
40.09
55.10
49.69
37.07
27.63
28.09

Annual Reports:

FY 2023
FY 2022
FY 2021
FY 2020
FY 2019
FY 2018
FY 2017
FY 2016
FY 2015
FY 2014

News Update:


  • Shilpa Medicare’s arm receives GMP Certification from COFEPRIS-Mexico for Karnataka facility
    23rd Jul 2024, 18:11 PM

    The said manufacturing facility had undergone a GMP inspection by COFEPRIS-Mexico from November 6, 2023 to November 10, 2023

    Read More
  • Shilpa Medicare’s arm receives registration approval for Adalimumab in Morocco
    23rd Jul 2024, 14:23 PM

    This is the first Biosimilar approval from any international market for high concentration Adalimumab developed by SBPL

    Read More
  • USFDA issues EIR to Shilpa Medicare’s Bio Analytical Laboratory
    25th Jun 2024, 15:13 PM

    The facility is classified as ‘No Action Indicated’

    Read More
  • Shilpa Medicare’s arm files first drug master file of Recombinant Human Albumin 20%
    4th Jun 2024, 17:06 PM

    Recombinant Human Albumin 20% targets to fulfil growing demand of human serum albumin to deliver current and growing market demand

    Read More
  • Shilpa Medicare - Quarterly Results
    23rd May 2024, 16:15 PM

    Read More
  • Shilpa Medicare’s marketing partner launches Pemetrexed injection
    18th Apr 2024, 12:11 PM

    The product has already been granted permanent J-code by U.S. CMS

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.